{"abstract":"Under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and Drug Enforcement Administration's (DEA) implementing regulations, after a patient and a practitioner have had an in-person medical evaluation, that practitioner may use telehealth to prescribe that patient any prescription for a controlled medication that the practitioner deems medically necessary. The Ryan Haight Act and DEA's implementing regulations do not apply to other forms of telemedicine, telehealth, or telepsychiatry that are not otherwise addressed in the Controlled Substances Act. This proposed rule applies only in limited circumstances when the prescribing practitioner wishes to prescribe controlled medications via the practice of telemedicine and has not otherwise conducted an in-person medical evaluation prior to the issuance of the prescription.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/03/01/2023-04248.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1300,"title":21},{"chapter":null,"citation_url":null,"part":1304,"title":21},{"chapter":null,"citation_url":null,"part":1306,"title":21}],"citation":"88 FR 12875","comment_url":null,"comments_close_on":"2023-03-31","correction_of":null,"corrections":[],"dates":"Electronic comments must be submitted, and written comments must be postmarked, on or before March 31, 2023. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.","disposition_notes":null,"docket_ids":["Docket No. DEA-407"],"dockets":[{"supporting_documents":[],"agency_name":"DEA","documents":[{"comment_count":35470,"comment_start_date":"2023-03-01","updated_at":"2023-04-25T01:01:24.145-04:00","comment_url":"https://www.regulations.gov/commenton/DEA-2023-0029-0001","allow_late_comments":null,"id":"DEA-2023-0029-0001","comment_end_date":"2023-04-01","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"DEA-2023-0029","title":"Telemedicine Prescribing of Controlled Substances (DEA407)"}],"document_number":"2023-04248","effective_on":null,"end_page":12890,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/03/01/2023-04248.xml","html_url":"https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-04248?publication_date=2023-03-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-03-01/2023-04248/mods.xml","not_received_for_publication":null,"page_length":16,"page_views":{"count":169295,"last_updated":"2026-05-11 10:15:15 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-03-01/pdf/2023-04248.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-04248.pdf?1677526230","publication_date":"2023-03-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/03/01/2023-04248.txt","regulation_id_number_info":{"1117-AB40":{"issue":"202410","html_url":"https://www.federalregister.gov/regulations/1117-AB40/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","title":"Special Registrations for Telemedicine and Limited State Telemedicine Registrations","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202410&RIN=1117-AB40&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"}},"regulation_id_numbers":["1117-AB40"],"regulations_dot_gov_info":{"supporting_documents":[],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/1117-AB40/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","title":"Special Registrations for Telemedicine and Limited State Telemedicine Registrations"},"comments_count":35470,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2023-0029","supporting_documents_count":0,"docket_id":"DEA-2023-0029","document_id":"DEA-2023-0029-0001","regulation_id_number":"1117-AB40","title":"Telemedicine Prescribing of Controlled Substances (DEA407)","checked_regulationsdotgov_at":"2023-04-26T01:00:10Z"},"regulations_dot_gov_url":null,"significant":true,"signing_date":null,"start_page":12875,"subtype":null,"title":"Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation","toc_doc":"Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation","toc_subject":null,"topics":["Administrative practice and procedure","Chemicals","Drug traffic control","Prescription drugs","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":88}